Advantage Trust Co Acquires 500 Shares of SPDR S&P Biotech ETF $XBI

Advantage Trust Co boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.4% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,245 shares of the exchange traded fund’s stock after purchasing an additional 500 shares during the period. Advantage Trust Co’s holdings in SPDR S&P Biotech ETF were worth $352,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in XBI. Advisor Resource Council bought a new position in SPDR S&P Biotech ETF during the first quarter worth about $423,000. Embree Financial Group lifted its stake in SPDR S&P Biotech ETF by 23.3% during the first quarter. Embree Financial Group now owns 4,314 shares of the exchange traded fund’s stock worth $350,000 after purchasing an additional 815 shares during the period. Econ Financial Services Corp lifted its stake in SPDR S&P Biotech ETF by 17.7% during the first quarter. Econ Financial Services Corp now owns 25,434 shares of the exchange traded fund’s stock worth $2,063,000 after purchasing an additional 3,824 shares during the period. Mission Hills Financial Advisory LLC increased its holdings in shares of SPDR S&P Biotech ETF by 0.7% during the first quarter. Mission Hills Financial Advisory LLC now owns 36,352 shares of the exchange traded fund’s stock worth $2,948,000 after buying an additional 241 shares in the last quarter. Finally, Spire Wealth Management increased its holdings in shares of SPDR S&P Biotech ETF by 1.6% during the first quarter. Spire Wealth Management now owns 17,509 shares of the exchange traded fund’s stock worth $1,420,000 after buying an additional 268 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 2.2%

NYSEARCA XBI opened at $110.17 on Tuesday. The firm has a market cap of $6.84 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. The company has a 50 day moving average of $96.56 and a 200-day moving average of $86.95. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $110.96.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.